Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Editor

Personal info

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

University of Arizona Health Sciences Center and Arizona Cancer Center

Tucson

AZ 85724

USA

Name/email consistency: high

University of Arizona Health Sciences Center and Arizona Cancer Center, Tucson, AZ 85724, USA. 2006 - 2008
Arizona Cancer Center, University of Arizona, 1515 North Campbell Avenue, Tucson, USA. 2007
Section of Hematology/Oncology, University Medical Center and Arizona Cancer Center, 1515 N Campbell Ave, PO Box 245024, USA. 2006

Gemcitabine plus celecoxib in patients with advanced or metastatic pancreatic adenocarcinoma: results of a phase II trial. Dragovich, T., Burris, H., Loehrer, P., Von Hoff, D.D., Chow, S., Stratton, S., Green, S., Obregon, Y., Alvarez, I., Gordon, M. Am. J. Clin. Oncol. (2008) [Pubmed]
Erlotinib plus gemcitabine in patients with unresectable pancreatic cancer and other solid tumors: phase IB trial. Dragovich, T., Huberman, M., Von Hoff, D.D., Rowinsky, E.K., Nadler, P., Wood, D., Hamilton, M., Hage, G., Wolf, J., Patnaik, A. Cancer Chemother. Pharmacol. (2007) [Pubmed]
A Phase 2 trial of the liposomal DACH platinum L-NDDP in patients with therapy-refractory advanced colorectal cancer. Dragovich, T., Mendelson, D., Kurtin, S., Richardson, K., Von Hoff, D., Hoos, A. Cancer Chemother. Pharmacol. (2006) [Pubmed]
Phase II trial of erlotinib in gastroesophageal junction and gastric adenocarcinomas: SWOG 0127. Dragovich, T., McCoy, S., Fenoglio-Preiser, C.M., Wang, J., Benedetti, J.K., Baker, A.F., Hackett, C.B., Urba, S.G., Zaner, K.S., Blanke, C.D., Abbruzzese, J.L. J. Clin. Oncol. (2006) [Pubmed]